Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

022025-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
272024-12

POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING HELD ON 27 DECEMBER 2024
092024-12

FORM OF PROXY FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 DECEMBER 2024 OR AT ANY ADJOURNMENT THEREOF
092024-12

NOTICE OF EXTRAORDINARY GENERAL MEETING
092024-12

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING
022024-12

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
292024-11

DELAY IN DESPATCH OF CIRCULAR
082024-11

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT
012024-11

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
022024-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
272024-09

2024 INTERIM REPORT
022024-09

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

1 2 3 4 5

The Enterprise OA